These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 1581439)

  • 1. Anticholinergic drug effects on quantitative electroencephalogram, visual evoked potential, and verbal memory.
    Sloan EP; Fenton GW; Standage KP
    Biol Psychiatry; 1992 Mar; 31(6):600-6. PubMed ID: 1581439
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of scopolamine on visual evoked potentials in aging and dementia.
    Ray PG; Meador KJ; Loring DW; Murro AM; Buccafusco JJ; Yang XH; Zamrini EY; Thompson WO; Thompson EE
    Electroencephalogr Clin Neurophysiol; 1991; 80(5):347-51. PubMed ID: 1716558
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cholinergic drug effects on a delayed conditional discrimination task in the rat.
    Herremans AH; Hijzen TH; Olivier B; Slangen JL
    Behav Neurosci; 1995 Jun; 109(3):426-35. PubMed ID: 7662153
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Synergistic anticholinergic and antiserotonergic effects in humans.
    Meador KJ; Loring DW; Hendrix N; Nichols ME; Oberzan R; Moore EE
    J Clin Exp Neuropsychol; 1995 Aug; 17(4):611-21. PubMed ID: 7593479
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Influence of prefeeding and scopolamine upon performance in a delayed matching-to-position task.
    Kirkby DL; Jones DN; Higgins GA
    Behav Brain Res; 1995 Mar; 67(2):221-7. PubMed ID: 7779293
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Changes in the human visual evoked potential caused by the anticholinergic agent hyoscine hydrobromide: comparison with results in Alzheimer's disease.
    Bajalan AA; Wright CE; van der Vliet VJ
    J Neurol Neurosurg Psychiatry; 1986 Feb; 49(2):175-82. PubMed ID: 3950635
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Human flash-VEP and quantitative EEG are independently affected by acute scopolamine.
    Sannita WG; Balestra V; DiBon G; Marotta V; Rosadini G
    Electroencephalogr Clin Neurophysiol; 1993 Apr; 86(4):275-82. PubMed ID: 7682931
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of scopolamine on verbal memory; a retrieval or acquisition deficit?
    Rusted JM; Warburton DM
    Neuropsychobiology; 1989; 21(2):76-83. PubMed ID: 2693994
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Time gradient for post-test vulnerability to scopolamine-induced amnesia following the initial acquisition session of a spatial reference memory task in mice.
    Toumane A; Durkin TP
    Behav Neural Biol; 1993 Sep; 60(2):139-51. PubMed ID: 8117239
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Scopolamine impairs memory performance and reduces frontal but not parietal visual P3 amplitude.
    Potter DD; Pickles CD; Roberts RC; Rugg MD
    Biol Psychol; 2000 Feb; 52(1):37-52. PubMed ID: 10686371
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Studies on human memory: the interactions of diazepam, scopolamine, and physostigmine.
    Ghoneim MM; Mewaldt SP
    Psychopharmacology (Berl); 1977 Mar; 52(1):1-6. PubMed ID: 403551
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Scopolamine impairs acquisition and facilitates consolidation of fear conditioning: differential effects for tone vs context conditioning.
    Young SL; Bohenek DL; Fanselow MS
    Neurobiol Learn Mem; 1995 Mar; 63(2):174-80. PubMed ID: 7663891
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Modelling dementia: effects of scopolamine on memory and attention.
    Broks P; Preston GC; Traub M; Poppleton P; Ward C; Stahl SM
    Neuropsychologia; 1988; 26(5):685-700. PubMed ID: 3211287
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of the effects of scopolamine and methylscopolamine on the performance of a fixed-ratio discrimination in squirrel monkeys.
    Pakarinen ED; Moerschbaecher JM
    Pharmacol Biochem Behav; 1993 Apr; 44(4):815-9. PubMed ID: 8469694
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Scopolamine deficits in negative patterning discrimination: evidence for a role of the central cholinergic system in retention but not acquisition of non-spatial configural association learning.
    Moran PM
    Behav Brain Res; 1992 Jun; 48(2):187-97. PubMed ID: 1616609
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Scopolamine and methylscopolamine differentially affect fixed-consecutive-number performance of male and female Wistar rats.
    van Haaren F; van Hest A; van Hattum T
    Pharmacol Biochem Behav; 1989 Jun; 33(2):361-5. PubMed ID: 2813474
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The effects of scopolamine on memory for time in rats and pigeons.
    Santi A; Weise L
    Pharmacol Biochem Behav; 1995; 51(2-3):271-7. PubMed ID: 7667339
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Reduction in ethanol preference following injection of centrally and peripherally acting antimuscarinic agents.
    Rezvani AH; Overstreet DH; Janowsky DS
    Alcohol Alcohol; 1990; 25(1):3-7. PubMed ID: 2334493
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The effect of scopolamine and physostigmine on working and reference memory in pigeons.
    Santi A; Bogles J; Petelka S
    Behav Neural Biol; 1988 Jan; 49(1):61-73. PubMed ID: 3345192
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A role for acetylcholine in spatial memory in turtles.
    Petrillo M; Ritter CA; Powers AS
    Physiol Behav; 1994 Jul; 56(1):135-41. PubMed ID: 8084892
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.